• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Issue Issue 2
Issue Issue 1
Volume Volume 1 (2019)
khalil, N. (2020). SOLUBLE CD14 AS A BIOMARKER OF SEPSIS AND ITS RELATION TO BLOOD CULTURES IN FEBRILE NEUTROPENIC ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY. ALEXMED ePosters, 2(2), 63-63. doi: 10.21608/alexpo.2020.50136.1073
Nahla kamal khalil. "SOLUBLE CD14 AS A BIOMARKER OF SEPSIS AND ITS RELATION TO BLOOD CULTURES IN FEBRILE NEUTROPENIC ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY". ALEXMED ePosters, 2, 2, 2020, 63-63. doi: 10.21608/alexpo.2020.50136.1073
khalil, N. (2020). 'SOLUBLE CD14 AS A BIOMARKER OF SEPSIS AND ITS RELATION TO BLOOD CULTURES IN FEBRILE NEUTROPENIC ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY', ALEXMED ePosters, 2(2), pp. 63-63. doi: 10.21608/alexpo.2020.50136.1073
khalil, N. SOLUBLE CD14 AS A BIOMARKER OF SEPSIS AND ITS RELATION TO BLOOD CULTURES IN FEBRILE NEUTROPENIC ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY. ALEXMED ePosters, 2020; 2(2): 63-63. doi: 10.21608/alexpo.2020.50136.1073

SOLUBLE CD14 AS A BIOMARKER OF SEPSIS AND ITS RELATION TO BLOOD CULTURES IN FEBRILE NEUTROPENIC ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY

Article 29, Volume 2, Issue 2, October 2020, Page 63-63  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2020.50136.1073
View on SCiNiTO View on SCiNiTO
Author
Nahla kamal khalil email
Departments of internal medicine, Hematology, Faculty of Medicine, University of Alexandria, Egypt
Abstract
• The incidence of acute leukemia in Egypt according to the National Population-Based Cancer Registry Program is about 3 cases per 100 000 population.
• Acute leukemia is classified according to WHO classification which incorporates clinical, prognostic, morphologic, immunophenotypic, and genetic data.
• Manifestations of acute leukemia can result from constitutional symptoms, bone marrow failure , infilteration of other organs and of leukocytosis.
• Acute leukemia patients are more prone to infections due to several factors including neutropenia, disruption of mucosal barriers and administration of immune suppressive drugs.
• The most popular tool used to predict the risk of complications associated with a febrile neutropenia is the Multinational Association of Supportive Care in Cancer (MASCC) score.
• The use of standard culture techniques for the detection and isolation of pathogenic organisms from a sterile body fluid specimen is still considered the “gold standard” for the diagnosis of infection and sepsis.
• Bacterial infections are commonly caused by six main etiologies: three Gram-negative (E. coli, Klebsiella sp and Pseudomonas aeruginosa) and three Gram-positive (S. aureus, S. epidermidis and S. Viridans).
• Presepsin is a new sepsis marker that show a potential as an early marker of sepsis recognition, for antimi‌crobial therapy monitoring and as a prognostic marker.
• Presepsin (sCD14-ST) is a peptide sized 13 kDa that is generated by proteolytic cleav‌age of soluble forms of CD14 cluster (sCD14).
• The major CRP drawback in sepsis lies in its lack of specificity.
Keywords
Febrile Neutropenia; Soluble Cd14; Sepsis
Statistics
Article View: 137
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.